Cookie Policy

This site uses cookies to store information on your computer.

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

 

 

First patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientshttp://www.terumo-europe.com/en-emea/news/first-patient-enrolled-in-major-new-study-investigating-abbreviated-dapt-post-stent-in-high-bleeding-risk-patientsFirst patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientsEmmen, The Netherlands03/04/2017 22:00:00
Terumo announces first commercial clinical case using QuiremSpheres®http://www.terumo-europe.com/en-emea/news/terumo-announces-first-commercial-clinical-case-using-quiremspheres®Terumo announces first commercial clinical case using QuiremSpheres®Leuven, Belgium27/03/2017 22:00:00
Terumo and Toxikon Europe NV announce a strategic partnershiphttp://www.terumo-europe.com/en-emea/news/terumo-and-toxikon-europe-nv-announce-a-strategic-partnershipTerumo and Toxikon Europe NV announce a strategic partnershipLeuven, Belgium05/03/2017 23:00:00

 

 

Terumo symposium at ECIO 2017http://www.terumo-europe.com/en-emea/Events/Terumo symposium at ECIO 2017.aspxTerumo symposium at ECIO 2017Spain23/04/2017 22:00:0024/04/2017 12:30:00Bilbaohttp://publishing-prd.terumo-europe.com/en-emea/events/terumo-symposium-at-ecio-2017, http://authoring-prd.terumo-europe.com/en-emea/events/terumo-symposium-at-ecio-2017
Charing Cross 2017http://www.terumo-europe.com/en-emea/Events/Charing Cross 2017.aspxCharing Cross 2017United Kingdom24/04/2017 22:00:0028/04/2017 09:40:00Londonhttps://www.cxsymposium.com/, https://www.cxsymposium.com/